Related Experiment Videos
Prospective comparative study of computer programs used for management of warfarin
L Poller1, D Wright, M Rowlands
1Withington Hospital, Manchester.
Journal of Clinical Pathology
|April 1, 1993
Summary
Computerized warfarin dosing systems offer effective outpatient anticoagulant control, matching traditional methods for most patients. These systems significantly improve control for those requiring intensive treatment with a higher target International Normalized Ratio (INR).
Area of Science:
- Pharmacology
- Medical Informatics
- Clinical Medicine
Background:
- Warfarin management requires precise dosing to maintain therapeutic anticoagulation and minimize bleeding risks.
- Traditional warfarin dosing relies on experienced clinicians, which can lead to variability and suboptimal control in certain patient groups.
Purpose of the Study:
- To evaluate the efficacy of three computerized warfarin dosing systems against standard clinical practice for outpatient management.
- To determine if computerized systems offer advantages in achieving target anticoagulation, particularly in patients requiring intensive management.
Main Methods:
- A pilot randomized controlled trial involving 186 outpatients on long-term or newly initiated warfarin therapy.
- Follow-up randomized studies were conducted on two of the three computerized systems.
Main Results:
- All three computerized systems demonstrated satisfactory warfarin control compared to the traditional dosing method.
- Computerized programs achieved significantly better anticoagulation control in patients with a higher target International Normalized Ratio (INR) range (3.0-4.5), where clinicians undertreated patients nearly 50% of the time.
Conclusions:
- Computer-based programs effectively support outpatient anticoagulant management with warfarin during both initial and long-term treatment phases.
- While comparable to experienced clinicians for general use, computerized systems show superior performance in achieving therapeutic goals for patients needing intensive anticoagulation (INR 3.0-4.5).
- Clinician dosing for intensive INR targets can be overly conservative, highlighting the benefit of computerized decision support in these cases.